Skip to main content

Booster vaccines against variants show promise in early studies, says Moderna

New vaccines designed to boost protection against new variants of the coronavirus have shown promise in preclinical studies, increasing the number of antibodies to a level comparable to that afforded by Moderna's original Covid-19 vaccine, the company said in a release on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.